Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Andrew H who wrote (1344)	6/18/1998 10:33:00 PM
From: Prospector	Read Replies (1) \| Respond to of 5402

Howdy Andrew My friend,, Prospector ( you can call me Old Port )

To: Andrew H who wrote (1344)	6/19/1998 10:11:00 AM
From: macker	Read Replies (2) \| Respond to of 5402

i agree, but as i understand it, batelle has never allowed numbers to be released in pr, that is just one of their rules, i was told 30 mm by a guy in the industry who is familiar with the situation, he said that 30mm is an industry standard umbrella number, he said it is almost never used because it never gets to the manufacturing phase because the company gets bought out. the credibility here i think is that they are with batelle period, not the 30 mm, batelle is not easy to get on your side. if the product merits continuation im sure batelle will have infinite funding available to them. i also agree that there will be no buyout till p1 is done or batelle tells the buyer that the product is the real deal, batelle has probably earned enough respect to make that call at this point in time. rumor, i repeat rumor, has it that batelle wants badly to buy a chunk of sgnc for themselves. macker